Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Oric Pharmaceuticals, Inc. (ORIC) had Return on Equity of -13.66% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-30.02M |
|
-- |
|
-- |
|
$32.72M |
|
$-32.72M |
|
$2.70M |
|
$-30.02M |
|
$-30.02M |
|
$-30.02M |
|
$-30.02M |
|
$-30.02M |
|
$-30.02M |
|
$-32.72M |
|
$-33.30M |
|
71.04M |
|
71.04M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$211.43M |
|
$3.02M |
|
$31.43M |
|
$242.86M |
|
$17.62M |
|
-- |
|
$5.50M |
|
$23.12M |
|
$219.74M |
|
$219.74M |
|
$219.74M |
|
71.08M |
|
| Cash Flow Statement Financials | |
$-32.53M |
|
$22.45M |
|
$0.01M |
|
$59.90M |
|
$49.83M |
|
$-10.07M |
|
$6.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-13.66% |
-13.66% |
|
-12.36% |
|
-13.66% |
|
$3.09 |
|
$-0.46 |
|
$-0.46 |
|